53008-63-2 Usage
Description
Methyl 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranoside is a synthetic compound derived from α-D-galactopyranoside, a monosaccharide sugar. It is characterized by its light yellow oil appearance and is primarily used in organic synthesis due to its unique chemical structure.
Uses
Used in Organic Synthesis:
Methyl 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranoside is used as a synthetic intermediate for the development of various organic compounds. Its application in this field is due to its unique chemical structure, which allows for the creation of a wide range of molecules with potential applications in different industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Methyl 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranoside is used as a key building block for the synthesis of complex carbohydrate-based drugs. Its ability to form various molecular structures makes it a valuable compound in the development of new medications with potential therapeutic benefits.
Used in Chemical Research:
Methyl 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranoside is also utilized in chemical research as a model compound for studying the properties and reactivity of carbohydrates. This helps researchers gain a better understanding of the fundamental principles governing carbohydrate chemistry, which can lead to the discovery of new applications and uses for these types of compounds.
Used in Material Science:
In the field of material science, Methyl 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranoside can be used as a component in the development of novel materials with specific properties. Its unique structure allows for the creation of materials with tailored characteristics, such as improved mechanical strength, thermal stability, or biocompatibility.
Overall, Methyl 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranoside is a versatile compound with a wide range of applications across various industries, including organic synthesis, pharmaceuticals, chemical research, and material science. Its unique chemical structure and properties make it a valuable asset in the development of new compounds and materials with potential benefits in multiple fields.
Check Digit Verification of cas no
The CAS Registry Mumber 53008-63-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,0,0 and 8 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 53008-63:
(7*5)+(6*3)+(5*0)+(4*0)+(3*8)+(2*6)+(1*3)=92
92 % 10 = 2
So 53008-63-2 is a valid CAS Registry Number.
53008-63-2Relevant articles and documents
Synthesis of C6′′-modified α-C-GalCer analogues as mouse and human iNKT cell agonists
Guillaume, Joren,Seki, Toshiyuki,Decruy, Tine,Venken, Koen,Elewaut, Dirk,Tsuji, Moriya,Van Calenbergh, Serge
, p. 2217 - 2225 (2017)
α-GalCer analogues that combine known Th1 polarizing C6′′-modifications with a C-glycosidic linkage were synthesized. We employed a protecting group strategy that allowed the preparation of both saturated and unsaturated derivatives with variable C6′′-substituents. Selected analogues demonstrate promising activity in mice. Interestingly, the introduction of a 6′′-O-pyridinylcarbamoyl substituent to α-C-GalCer restores its antigenicity in human iNKT cells.
Streamlined access to carbohydrate building blocks: Methyl 2,4,6-tri-O-benzyl-α-D-glucopyranoside
Demchenko, Alexei V.,Kashiwagi, Gustavo A.,Shrestha, Ganesh,Stine, Keith J.
, (2021/12/02)
Presented herein is an improved synthesis of a common 3-OH glycosyl acceptor. This compound is a building block that is routinely synthesized by many research groups to be used in glycosylation refinement studies. The only known direct synthesis by Koto lacks regioselectivity and relies on chromatography separation using hazardous solvents. Our improved synthetic approach relies on Koto's selective benzylation protocol, but it is followed by acylation-purification-deacylation sequence. Although this approach involves additional manipulations, it provides consistent results and is superior to other indirect strategies. Also obtained, albeit in minor quantities, is 4-OH acceptor, another common building block.
Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors
Ahuja-Casarín, Ana I.,Merino-Montiel, Penélope,Vega-Baez, José Luis,Montiel-Smith, Sara,Fernandes, Miguel X.,Lagunes, Irene,Maya, Inés,Padrón, José M.,López, óscar,Fernández-Bola?os, José G.
, p. 138 - 146 (2020/11/27)
We have designed unprecedented cholinesterase inhibitors based on 1-deoxynojirimycin as potential anti-Alzheimer’s agents. Compounds are comprised of three key structural motifs: the iminosugar, for interaction with cholinesterase catalytic anionic site (